Nanexa is developing the next generation of Long Acting Injectables (LAIs), utilizing our innovative PharmaShell® drug delivery system by coating with atomic layer precision (ALD). PharmaShell® has the potential to revolutionalise treatment paradigms with several key benefits :

• Reduced treatment burden by lowering injection frequency; potential for 1 to 6-month controlled release)
• Steady, tailored release of the therapeutic; leading to stable plasma levels and reduction in side effects
• High drug load (>80%) with a small injection volume
• Broad compatibility and stability (requiring only room temperature storage)

Proven on broad range of APIs. Demonstrated clinical PoC with a monthly GLP-1 - without the typical GI side-effects.